Replies to post #32637 on Relief Therapeutics Holding AG (RLFTF)

[tiggerifficm4]

Would be a great holiday boost to all of us long time supporters rooting for this treatment to get those in need.

Nice little tweet from NeuroRX earlier.

For all those celebrating this holiday season, we wish you a safe, healthy and happy holidays.

Follow our journey at https://t.co/PD0OtotKXr pic.twitter.com/B6ECiQxZuY

— NRx Pharmaceuticals (@NRxPharma) December 18, 2020

[Dash82]

I’m curious why you are using the 165 number in regards to EAP patients? 165 enrollment is for the full trial. Why would they give any update specifically at 165 patients from EAP?

I’m not saying there won’t be an update from EAP, but could be any number greater than 90 patients from the last update. Could be more or less than 165. Though to be honest I don’t expect anything before results from the real trial since it’s almost January and I think more good results from EAP won’t mean much. I’d actually be concerned with release of more EAP data this close to the finish line as it would seem like a pump before poor trial results.